Research and Markets: Idiopathic Juvenile Arthritis (Still’s Disease) Global Clinical Trials Review H2, 2015 – Analysis, Technologies & Forecasts

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/rpslw5/idiopathic)
has announced the addition of the “Idiopathic
Juvenile Arthritis (Still’s Disease) Global Clinical Trials Review, H2,
2015″ report to their offering.

Our clinical trial report, Idiopathic Juvenile Arthritis (Still’s
Disease) Global Clinical Trials Review, H2, 2015″ provides an overview
of Idiopathic Juvenile Arthritis (Still’s Disease) clinical trials
scenario. This report provides top line data relating to the clinical
trials on Idiopathic Juvenile Arthritis (Still’s Disease). Report
includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). Clinical Trial Reports are generated using
Our proprietary database – Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe. Clinical
trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.

Key Topics Covered:

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Benefits of this Report:

• Assists in formulating key business strategies with regards to
  investment
• Helps in identifying prominent locations for conducting clinical
  trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which
  helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by
  country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing
  a comparative scenario of completed and uncompleted (terminated,
  suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global,
  regional and country level

Companies Mentioned:

• F. Hoffmann-La Roche Ltd.
• Pfizer Inc.
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Parexel International Corporation
• Johnson & Johnson
• Italfarmaco S.p.A.
• Arthritis Research UK
• Amgen Inc.
• AB2 Bio Ltd.

For more information visit http://www.researchandmarkets.com/research/rpslw5/idiopathic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Clinical
Trials